HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Baorui Liu Selected Research

Signet Ring Cell Carcinoma

6/2021KRAS gene status in gastric signet-ring cell carcinoma patients and acts as biomarker of MEK inhibitor.
10/2019Survival benefit of palliative gastrectomy followed by chemotherapy in stage IV gastric signet ring cell carcinoma patients: A large population-based study.
6/2017The PD-1, PD-L1 expression and CD3+ T cell infiltration in relation to outcome in advanced gastric signet-ring cell carcinoma, representing a potential biomarker for immunotherapy.
1/2014TAZ is highly expressed in gastric signet ring cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Baorui Liu Research Topics

Disease

162Neoplasms (Cancer)
11/2022 - 10/2007
63Stomach Neoplasms (Stomach Cancer)
06/2022 - 10/2007
16Neoplasm Metastasis (Metastasis)
06/2022 - 04/2008
15Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 04/2012
12Lung Neoplasms (Lung Cancer)
01/2022 - 09/2008
11Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2022 - 02/2016
11Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2022 - 11/2009
8Breast Neoplasms (Breast Cancer)
01/2022 - 04/2008
8Adenocarcinoma
01/2022 - 06/2013
7Disease Progression
11/2022 - 03/2012
7Melanoma (Melanoma, Malignant)
04/2022 - 11/2012
7Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 05/2009
6Hepatocellular Carcinoma (Hepatoma)
01/2021 - 01/2013
6Carcinoma (Carcinomatosis)
05/2018 - 08/2010
5Carcinogenesis
10/2021 - 05/2009
5Liver Neoplasms (Liver Cancer)
01/2021 - 02/2011
5Colonic Neoplasms (Colon Cancer)
01/2020 - 02/2011
4Inflammation (Inflammations)
07/2022 - 04/2013
4Signet Ring Cell Carcinoma
06/2021 - 01/2014
4Circulating Neoplastic Cells
01/2020 - 03/2014
4Ascites
01/2019 - 09/2008
4Nasopharyngeal Carcinoma
01/2018 - 11/2016
4Hyperthermia
01/2012 - 06/2007
3Testicular Neoplasms (Testicular Cancer)
10/2022 - 05/2019
3Hypertension (High Blood Pressure)
12/2021 - 04/2013
3Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2021 - 03/2008
3Esophageal Neoplasms (Esophageal Cancer)
01/2021 - 01/2013
3Malignant Pleural Effusion
01/2019 - 01/2012
2Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 10/2017

Drug/Important Bio-Agent (IBA)

29Biomarkers (Surrogate Marker)IBA
08/2022 - 04/2008
25Pharmaceutical PreparationsIBA
03/2022 - 04/2008
22Docetaxel (Taxotere)FDA Link
06/2022 - 06/2007
21Peptides (Polypeptides)IBA
06/2022 - 12/2011
20Messenger RNA (mRNA)IBA
07/2022 - 03/2008
16Paclitaxel (Taxol)FDA LinkGeneric
12/2021 - 08/2008
15AntigensIBA
10/2022 - 01/2017
14Proteins (Proteins, Gene)FDA Link
07/2022 - 11/2010
13Cisplatin (Platino)FDA LinkGeneric
03/2020 - 03/2008
11Recombinant ProteinsIBA
03/2022 - 02/2015
10ErbB Receptors (EGF Receptor)IBA
03/2022 - 01/2013
9Immune Checkpoint InhibitorsIBA
01/2022 - 06/2017
8VaccinesIBA
11/2022 - 01/2018
8LigandsIBA
01/2021 - 01/2016
8Antineoplastic Agents (Antineoplastics)IBA
03/2020 - 06/2007
7Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2022 - 10/2007
7gambogic acidIBA
01/2020 - 04/2008
6ParaffinIBA
07/2022 - 09/2011
6GelatinasesIBA
06/2022 - 11/2012
6Biological ProductsIBA
03/2022 - 12/2012
6MicroRNAs (MicroRNA)IBA
01/2020 - 08/2010
6Pemetrexed (MTA)FDA Link
01/2017 - 11/2012
5Monoclonal AntibodiesIBA
08/2022 - 01/2013
5Formaldehyde (Formol)FDA Link
07/2022 - 09/2011
5Therapeutic UsesIBA
01/2022 - 06/2013
5HydrogelsIBA
01/2020 - 01/2018
5Fluorouracil (Carac)FDA LinkGeneric
03/2017 - 03/2008
5tetrandrineIBA
02/2012 - 10/2007
4CytokinesIBA
06/2022 - 01/2018
4salinomycinIBA
06/2022 - 01/2018
4GemcitabineFDA Link
01/2022 - 05/2011
4Tumor Biomarkers (Tumor Markers)IBA
01/2022 - 12/2010
4Programmed Cell Death 1 ReceptorIBA
12/2021 - 01/2020
4PlatinumIBA
12/2021 - 10/2007
4Cancer VaccinesIBA
11/2021 - 05/2019
4Drug CarriersIBA
02/2019 - 01/2011
4Irinotecan (Camptosar)FDA LinkGeneric
01/2017 - 01/2013
3NanovaccinesIBA
04/2022 - 01/2022
3LipidsIBA
01/2022 - 01/2018
3Phosphotransferases (Kinase)IBA
08/2021 - 08/2010
3apatinibIBA
01/2020 - 07/2016
3Fibroins (Fibroin)IBA
01/2020 - 01/2016
3Long Noncoding RNAIBA
01/2020 - 01/2019
3Neoplasm Antigens (Tumor Antigens)IBA
07/2018 - 01/2017
3Tyrosine Kinase InhibitorsIBA
03/2018 - 05/2016
3Thymidylate SynthaseIBA
02/2014 - 09/2012
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2014 - 03/2009
3AlkaloidsIBA
08/2013 - 08/2010
3GelatinIBA
03/2012 - 06/2011
3MicellesIBA
08/2008 - 06/2007
2SuspensionsIBA
06/2022 - 05/2018
2Chimeric Antigen ReceptorsIBA
01/2022 - 10/2021
2Circulating Tumor DNAIBA
01/2022 - 04/2017
2Epidermal Growth Factor (EGF)IBA
01/2022 - 02/2015
2130-nm albumin-bound paclitaxelIBA
01/2022 - 01/2022
2Protein Subunit VaccinesIBA
01/2022 - 05/2019
2sintilimabIBA
01/2022 - 01/2021
2B7-H1 AntigenIBA
12/2021 - 10/2017
2RamucirumabIBA
12/2021 - 07/2016
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
08/2021 - 06/2021

Therapy/Procedure

58Therapeutics
11/2022 - 05/2009
38Drug Therapy (Chemotherapy)
08/2022 - 10/2007
25Immunotherapy
06/2022 - 01/2017
23Radiotherapy
04/2022 - 01/2015
8Chemoradiotherapy
01/2022 - 01/2013
4Cell- and Tissue-Based Therapy (Cell Therapy)
11/2022 - 01/2018
4Gastrectomy
07/2022 - 12/2014
4Neoadjuvant Therapy
01/2020 - 12/2014
3Chinese Traditional Medicine (Traditional Chinese Medicine)
04/2020 - 08/2012
2Combination Drug Therapy (Combination Chemotherapy)
08/2022 - 12/2010
2Molecular Targeted Therapy
08/2021 - 03/2020